The Genomic Architecture of Circulating Cytokine Levels Points to Drug Targets for Immune-Related Diseases
Marek J. Konieczny, Murad Omarov, Rainer Malik, View ORCID ProfileTom G. Richardson, Sebastian-Edgar Baumeister, View ORCID ProfileJürgen Bernhagen, Martin Dichgans, Marios K. Georgakis
doi: https://doi.org/10.1101/2024.04.19.24306036
Marek J. Konieczny
1Institute for Stroke and Dementia Research (ISD), LMU University Hospital, LMU Munich, Munich, Germany
Murad Omarov
1Institute for Stroke and Dementia Research (ISD), LMU University Hospital, LMU Munich, Munich, Germany
Rainer Malik
1Institute for Stroke and Dementia Research (ISD), LMU University Hospital, LMU Munich, Munich, Germany
Tom G. Richardson
2Medical Research Council (MRC) Integrative Epidemiology Unit (IEU), University of Bristol, Bristol, United Kingdom
3Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
Sebastian-Edgar Baumeister
4Institute of Health Services Research in Dentistry, University of Münster, Münster, Germany
Jürgen Bernhagen
1Institute for Stroke and Dementia Research (ISD), LMU University Hospital, LMU Munich, Munich, Germany
5Munich Cluster for Systems Neurology (SyNergy), Munich, Germany
6German Center for Neurodegenerative Diseases (DZNE), Munich, Germany
Martin Dichgans
1Institute for Stroke and Dementia Research (ISD), LMU University Hospital, LMU Munich, Munich, Germany
5Munich Cluster for Systems Neurology (SyNergy), Munich, Germany
6German Center for Neurodegenerative Diseases (DZNE), Munich, Germany
6bGerman Centre for Cardiovascular Research (DZHK, Munich), Munich, Germany
Marios K. Georgakis
1Institute for Stroke and Dementia Research (ISD), LMU University Hospital, LMU Munich, Munich, Germany
5Munich Cluster for Systems Neurology (SyNergy), Munich, Germany
7Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA
Data Availability
GWAS meta-analysis summary statistics will be available at GWAS catalog
Posted April 22, 2024.
The Genomic Architecture of Circulating Cytokine Levels Points to Drug Targets for Immune-Related Diseases
Marek J. Konieczny, Murad Omarov, Rainer Malik, Tom G. Richardson, Sebastian-Edgar Baumeister, Jürgen Bernhagen, Martin Dichgans, Marios K. Georgakis
medRxiv 2024.04.19.24306036; doi: https://doi.org/10.1101/2024.04.19.24306036
The Genomic Architecture of Circulating Cytokine Levels Points to Drug Targets for Immune-Related Diseases
Marek J. Konieczny, Murad Omarov, Rainer Malik, Tom G. Richardson, Sebastian-Edgar Baumeister, Jürgen Bernhagen, Martin Dichgans, Marios K. Georgakis
medRxiv 2024.04.19.24306036; doi: https://doi.org/10.1101/2024.04.19.24306036
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (710)
- Anesthesia (201)
- Cardiovascular Medicine (2952)
- Dermatology (250)
- Emergency Medicine (441)
- Epidemiology (12758)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4593)
- Geriatric Medicine (420)
- Health Economics (729)
- Health Informatics (2923)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (925)
- Medical Education (427)
- Medical Ethics (116)
- Nephrology (469)
- Neurology (4366)
- Nursing (237)
- Nutrition (640)
- Oncology (2274)
- Ophthalmology (647)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1197)
- Primary Care Research (499)
- Public and Global Health (6949)
- Radiology and Imaging (1531)
- Respiratory Medicine (915)
- Rheumatology (439)
- Sports Medicine (385)
- Surgery (490)
- Toxicology (60)
- Transplantation (212)
- Urology (181)